Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2026
Download Free Sample Buy Now
Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2026

Global Outlook – By Component (Software, Hardware, Services), By Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies), By Deployment Mode (Cloud-Based, On-Premises), By Diagnosis Type (Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types), By End-User (Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

• Artificial Intelligence (AI)-Powered Rare Disease Diagnosis market size has reached to $1.99 billion in 2025

• Expected to grow to $7.08 billion in 2030 at a compound annual growth rate (CAGR) of 28.9%

• Growth Driver: Increasing Prevalence Of Autoimmune Disorders Is Fueling The Growth Of The Market Due To Rising Demand For Early Diagnosis And Personalized Treatment

• Market Trend: Advancements In Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Unified Genomic Diagnostics And Innovative Solutions

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?

Artificial intelligence (AI)-powered rare disease diagnosis refers to the use of advanced algorithms and machine learning techniques to identify uncommon medical conditions with high accuracy. These systems analyze complex patient data, including genetic, clinical, and imaging information, to detect patterns that may be missed by traditional diagnostic methods.

The main components of artificial intelligence (AI)-powered rare disease diagnosis are software, hardware, and services. Software is a collection of programs, data, and instructions that tell a computer or device how to perform specific tasks or operations. The multiple technologies are machine learning, deep learning, natural language processing, computer vision, and others. The different deployment modes are cloud-based and on-premises solutions. The various diagnosis types are genetic disorders, autoimmune disorders, metabolic disorders, infectious diseases, and others, and they are used by several end-users such as hospitals, diagnostic centers, research institutes, specialty clinics, and others.

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Global Report 2026 Market Report bar graph

What Is The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size and Share 2026?

The artificial intelligence (ai)-powered rare disease diagnosis market size has grown exponentially in recent years. It will grow from $1.99 billion in 2025 to $2.56 billion in 2026 at a compound annual growth rate (CAGR) of 28.9%. The growth in the historic period can be attributed to increasing diagnostic challenges for rare conditions, expansion of genetic testing availability, rising investments in rare disease research, growing use of data analytics in healthcare, early adoption of ai-driven diagnostic tools.

What Is The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Growth Forecast?

The artificial intelligence (ai)-powered rare disease diagnosis market size is expected to see exponential growth in the next few years. It will grow to $7.08 billion in 2030 at a compound annual growth rate (CAGR) of 28.9%. The growth in the forecast period can be attributed to increasing focus on personalized medicine, rising deployment of ai-assisted clinical decision support, expansion of genomic sequencing integration, growing investment in rare disease screening programs, increasing demand for diagnostic efficiency. Major trends in the forecast period include increasing use of ai for pattern recognition in rare diseases, rising adoption of genomic data analytics platforms, growing integration of multi-modal patient data, expansion of cloud-based diagnostic solutions, enhanced focus on early and accurate diagnosis.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Segmentation

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies

3) By Deployment Mode: Cloud-Based, On-Premises

4) By Diagnosis Type: Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types

5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users

Subsegments:

1) By Software: Clinical Decision Support, Data Analytics Platforms, Genomic Interpretation Tools, Machine Learning Algorithms, Diagnostic Reporting Software

2) By Hardware: Sequencing Instruments, Imaging Devices, Laboratory Equipment, Computational Servers, Diagnostic Sensors

3) By Services: Consulting Services, Implementation And Integration, Training And Support, Data Management Services, Maintenance And Upgrades

What Is The Driver Of The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?

The increasing prevalence of autoimmune disorders is expected to propel the growth of the artificial intelligence (AI)-powered rare disease diagnosis market going forward. Autoimmune disorders are conditions where the immune system mistakenly attacks the body’s own healthy cells and tissues, causing inflammation and damage. The prevalence of autoimmune disorders is due to the growing number of individuals experiencing immune system dysfunctions, leading to higher demand for early diagnosis, advanced treatments, and continuous monitoring to manage symptoms effectively. Artificial intelligence (AI)-powered rare disease diagnosis supports autoimmune disorder management by rapidly identifying complex conditions, supporting personalized treatment decisions, and improving overall diagnostic accuracy. For instance, in January 2025, according to the Mayo Clinic, a US-based nonprofit academic medical center, reports that about 15 million people are estimated to have one or more of 105 autoimmune diseases. Therefore, the increasing prevalence of autoimmune disorders drives the growth of the artificial intelligence (AI)-powered rare disease diagnosis industry.

Key Players In The Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

Major companies operating in the artificial intelligence (AI)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project

Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Trends and Insights

Major companies operating in the artificial intelligence (AI)-powered rare disease diagnosis market are focusing on developing innovative technology, such as unified genomic diagnostics solutions, to enhance diagnostic accuracy, reduce turnaround time, and provide more comprehensive insights into complex genetic disorders. A unified genomic diagnostics solution is an integrated system combining whole-genome sequencing and artificial intelligence (AI)-driven analysis to deliver complete genetic insights. For instance, in October 2023, Oxford Nanopore Technologies plc, a UK-based biotechnology company, and Fabric Genomics Inc., a US-based artificial intelligence (AI)-based company, launched an integrated whole-genome sequencing solution that aims to accelerate rare disease diagnosis by combining rapid sequencing with AI-driven variant interpretation for more accurate and actionable clinical insights. The launch integrates real-time nanopore sequencing with artificial intelligence (AI)-powered genomic analysis to rapidly identify rare genetic variants. It delivers comprehensive, actionable insights to clinicians, enhancing diagnostic speed and accuracy for pediatric care.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?

In September 2025, SeqOne, a France-based provider of AI powered genomic analysis and clinical decision support tools, acquired Congenica for an undisclosed amount. With this acquisition, SeqOne aims to merge its AI-driven next generation sequencing (NGS) platform with Congenica’s clinical interpretation expertise and decision support software, enhancing its capacity for rare disease and inherited disease diagnostics, expanding its global reach, and creating a software pure leader in clinical genomics. Congenica is a UK-based provider of genomic data analysis and interpretation solutions, offering clinical decision support and variant interpretation services for rare, inherited, and genetic diseases.

Regional Outlook

North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?

The artificial intelligence (AI)-powered rare disease diagnosis market includes revenues earned by entities by providing services such as genomic sequencing analysis, clinical data integration, artificial intelligence (AI)-based imaging interpretation, predictive analytics for rare diseases, and personalized treatment recommendations. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered rare disease diagnosis market also includes sales of genetic testing kits, imaging scanners, biosensors, lab automation instruments, point-of-care testing devices, wearable health monitors, sequencing machines, microfluidic chips, and pathology slide scanners. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2026?

The artificial intelligence (ai)-powered rare disease diagnosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-powered rare disease diagnosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.56 billion
Revenue Forecast In 2035 $7.08 billion
Growth Rate CAGR of 28.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Component, Technology, Deployment Mode, Diagnosis Type, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Use Of Ai For Pattern Recognition In Rare Diseases

4.2.2 Rising Adoption Of Genomic Data Analytics Platforms

4.2.3 Growing Integration Of Multi-Modal Patient Data

4.2.4 Expansion Of Cloud-Based Diagnostic Solutions

4.2.5 Enhanced Focus On Early And Accurate Diagnosis

5. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Research Institutes

5.4 Specialty Clinics

5.5 Genetic Testing Laboratories

6. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Segmentation

9.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Software, Hardware, Services

9.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies

9.3. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cloud-Based, On-Premises

9.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types

9.5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users

9.6. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinical Decision Support, Data Analytics Platforms, Genomic Interpretation Tools, Machine Learning Algorithms, Diagnostic Reporting Software

9.7. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sequencing Instruments, Imaging Devices, Laboratory Equipment, Computational Servers, Diagnostic Sensors

9.8. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Consulting Services, Implementation And Integration, Training And Support, Data Management Services, Maintenance And Upgrades

10. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Regional And Country Analysis

10.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

11.1. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

12.1. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

13.1. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

14.1. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

15.1. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

16.1. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

17.1. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

18.1. Taiwan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

19.1. South East Asia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

20.1. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

21.1. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

22.1. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

23.1. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

24.1. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

25.1. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

26.1. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

27.1. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

28.1. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

29.1. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

30.1. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

31.1. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

32.1. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

33.1. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

34.1. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Landscape And Company Profiles

36.1. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Company Profiles

36.3.1. Ambry Genetics Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.2. MedGenome Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sophia Genetics SA Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Variantyx Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Atropos Health Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Other Major And Innovative Companies

Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project

38. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

40. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market High Potential Countries, Segments and Strategies

40.1 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2030 - Countries Offering Most New Opportunities

40.2 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2030 - Segments Offering Most New Opportunities

40.3 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Overview Of Key Products - Product Examples
  • Table 2: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Supply Chain Analysis
  • Table 4: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Raw Material Providers
  • Table 5: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Resource Providers
  • Table 6: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Manufacturers (Suppliers)
  • Table 7: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Distributors And Channel Partners
  • Table 8: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Key Technologies & Future Trends
  • Table 9: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Trends
  • Table 10: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major End Users
  • Table 11: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - TAM, US$ Billion, 2025
  • Table 15: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - Company Scoring Matrix
  • Table 99: Ambry Genetics Corporation Financial Performance
  • Table 100: MedGenome Inc. Financial Performance
  • Table 101: Sophia Genetics SA Financial Performance
  • Table 102: Variantyx Inc. Financial Performance
  • Table 103: Atropos Health Inc. Financial Performance
  • Table 104: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Competitive Dashboard
  • Table 106: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030
  • Table 108: Global, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 109: Global, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Gain ($ Billion), Segmentation By Deployment Mode, 2025 – 2030

List Of Figures

    Figure 1: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Supply Chain Analysis
  • Figure 4: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Raw Material Providers
  • Figure 5: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Resource Providers
  • Figure 6: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Distributors And Channel Partners
  • Figure 8: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Key Technologies & Future Trends
  • Figure 9: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major Trends
  • Figure 10: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Major End Users
  • Figure 11: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - TAM, US$ Billion, 2025
  • Figure 15: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - Company Scoring Matrix
  • Figure 99: Ambry Genetics Corporation Financial Performance
  • Figure 100: MedGenome Inc. Financial Performance
  • Figure 101: Sophia Genetics SA Financial Performance
  • Figure 102: Variantyx Inc. Financial Performance
  • Figure 103: Atropos Health Inc. Financial Performance
  • Figure 104: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Competitive Dashboard
  • Figure 106: Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030
  • Figure 108: Global, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 109: Global, Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Gain ($ Billion), Segmentation By Deployment Mode, 2025 – 2030

Emerging Growth Drivers in the Erdheim Chester Disease Market Landscape: Increasing Number Of Clinical Trials To Boost Chester Diseases

Read More About Emerging Growth Drivers in the Erdheim Chester Disease Market Landscape: Increasing Number Of Clinical Trials To Boost Chester Diseases

Next-Gen Vertebroplasty And Kyphoplasty : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Vertebroplasty And Kyphoplasty : Market Forecast, Transformation, and Long-Term Trajectories

Viral Hepatitis Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Viral Hepatitis Growth Trajectory: Key Forecasts and Strategic Insights

Virtual Colonoscopy Software Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Virtual Colonoscopy Software Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Artificial Intelligence in Healthcare Diagnosis Market Report 2026 - Global Outlook – By Component (Software, Services, Hardware), By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Othe...

Artificial Intelligence In The Diagnostic Market Report 2026 - Global Outlook – By Component (Hardware, Software, Services), By Technology (Machine Learning, NLP (Natural Language Processing), Context-Aware Computing, Co...

AI In Medical Diagnostics Market Report 2026 - Global Outlook – By Component (Software, Services), By Technology (Natural Language Processing, Computer Vision, Machine Learning, Context-Aware Computing, Other Technologie...

Artificial Intelligence In Cancer Diagnostics Market Report 2026 - Global Outlook – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, B...

AI In Cancer Diagnostics Market Report 2026 - Global Outlook – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And...

Artificial Intelligence (AI) In Clinical Trials Market Report 2026 - Global Outlook – By Offering (Software, Services), By Process (Trial Design, Patient Selection, Site Selection, Patient Monitoring), By Application (On...

Artificial Intelligence in Diabetes Management Market Report 2026 - Global Outlook – By Device (Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices), By Techniques (Case-Based Reasoning, Intelligent ...

Artificial Intelligence (AI) in Precision Medicine Market Report 2026 - Global Outlook – By Component (Hardware, Software, Service), By Technology (Deep Learning, Querying Method, Natural Language Processing, Context Awa...

Frequently Asked Questions

The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2026 market was valued at $1.99 billion in 2025, increased to $2.56 billion in 2026, and is projected to reach $7.08 billion by 2030. request a sample here

The expected CAGR for the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2026 market during the forecast period 2025–2030 is 28.9%. request a sample here

Major growth driver of the market includes: Increasing Prevalence Of Autoimmune Disorders Is Fueling The Growth Of The Market Due To Rising Demand For Early Diagnosis And Personalized Treatment in the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2026 market. For further insights on this market, request a sample here

The artificial intelligence (AI)-powered rare disease diagnosis market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies
3) By Deployment Mode: Cloud-Based, On-Premises
4) By Diagnosis Type: Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types
5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users Subsegments:
1) By Software: Clinical Decision Support, Data Analytics Platforms, Genomic Interpretation Tools, Machine Learning Algorithms, Diagnostic Reporting Software
2) By Hardware: Sequencing Instruments, Imaging Devices, Laboratory Equipment, Computational Servers, Diagnostic Sensors
3) By Services: Consulting Services, Implementation And Integration, Training And Support, Data Management Services, Maintenance And Upgrades request a sample here

Major trend in this market includes: Advancements In Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Unified Genomic Diagnostics And Innovative Solutions For further insights on this market, request a sample here.

Major companies operating in the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report 2026 market are Major companies operating in the artificial intelligence (AI)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project request a sample here.

North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered rare disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us